Onconetix Inc.

ONCO | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.68

+$0.03 (+3.83%)

At close: Sep 22, 2026, 4:00 PM ET

$0.69

+$0.01 (+1.47%)

After-hours: Sep 22, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.83%

(1D)

Rating

Updated: Aug 11, 2026

18.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.45M

1D Range

0.64 0.70

52W Range

0.59 209.50

Valuation (TTM)

PE -0.07

PB 0.17

EV/EBITDA 0.35

Valuation (NTM)

Forward PE N/A

Forward PEG -0.01

Price Target N/A

Cash Flow

FCF Yield -439.1%

SBC Adj. FCF Yield -441.0%

SBC Impact -0.4%

Margins

Gross Margin 80.4%

Operating Margin -1265.5%

FCF Margin -1596.1%

Growth (CAGR)

Revenue 3Y | 5Y -35.7% | 38.1%

Dil EPS 3Y | 5Y -2.3% | -50.6%

FCF 3Y | 5Y 26.3% | -19.2%

Returns

ROA -62.1%

ROE -92.0%

ROIC -59.8%

Financial Health

Net Cash

$5.76M

Current Ratio 2.21

Interest Coverage -26.28

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The compa...

Sector Healthcare

Industry Biotechnology

Employees 2

IPO Date Feb 17, 2022

Website www.onconetix.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞